140 related articles for article (PubMed ID: 27231468)
1. EDI3, a key enzyme of choline metabolism controls tumour cell migration.
Marchan R; Stewart JD; Lesjak M
EXCLI J; 2012; 11():260-2. PubMed ID: 27231468
[No Abstract] [Full Text] [Related]
2. Choline-releasing glycerophosphodiesterase EDI3 drives tumor cell migration and metastasis.
Stewart JD; Marchan R; Lesjak MS; Lambert J; Hergenroeder R; Ellis JK; Lau CH; Keun HC; Schmitz G; Schiller J; Eibisch M; Hedberg C; Waldmann H; Lausch E; Tanner B; Sehouli J; Sagemueller J; Staude H; Steiner E; Hengstler JG
Proc Natl Acad Sci U S A; 2012 May; 109(21):8155-60. PubMed ID: 22570503
[TBL] [Abstract][Full Text] [Related]
3. Inhibiting the glycerophosphodiesterase EDI3 in ER-HER2+ breast cancer cells resistant to HER2-targeted therapy reduces viability and tumour growth.
Keller M; Rohlf K; Glotzbach A; Leonhardt G; Lüke S; Derksen K; Demirci Ö; Göçener D; AlWahsh M; Lambert J; Lindskog C; Schmidt M; Brenner W; Baumann M; Zent E; Zischinsky ML; Hellwig B; Madjar K; Rahnenführer J; Overbeck N; Reinders J; Cadenas C; Hengstler JG; Edlund K; Marchan R
J Exp Clin Cancer Res; 2023 Jan; 42(1):25. PubMed ID: 36670508
[TBL] [Abstract][Full Text] [Related]
4. EDI3 links choline metabolism to integrin expression, cell adhesion and spreading.
Lesjak MS; Marchan R; Stewart JD; Rempel E; Rahnenführer J; Hengstler JG
Cell Adh Migr; 2014; 8(5):499-508. PubMed ID: 25482527
[TBL] [Abstract][Full Text] [Related]
5. Choline-releasing glycerophosphodiesterase EDI3 links the tumor metabolome to signaling network activities.
Marchan R; Lesjak MS; Stewart JD; Winter R; Seeliger J; Hengstler JG
Cell Cycle; 2012 Dec; 11(24):4499-506. PubMed ID: 23114620
[TBL] [Abstract][Full Text] [Related]
6. Glycerol-3-phosphate Acyltransferase 1 Promotes Tumor Cell Migration and Poor Survival in Ovarian Carcinoma.
Marchan R; Büttner B; Lambert J; Edlund K; Glaeser I; Blaszkewicz M; Leonhardt G; Marienhoff L; Kaszta D; Anft M; Watzl C; Madjar K; Grinberg M; Rempel E; Hergenröder R; Selinski S; Rahnenführer J; Lesjak MS; Stewart JD; Cadenas C; Hengstler JG
Cancer Res; 2017 Sep; 77(17):4589-4601. PubMed ID: 28652252
[TBL] [Abstract][Full Text] [Related]
7. Highlight report: The EDI3-GPAM axis in tumor cell migration.
Hassan R
EXCLI J; 2017; 16():1148-1149. PubMed ID: 29285011
[No Abstract] [Full Text] [Related]
8. Anticancer Activity of the Choline Kinase Inhibitor PL48 Is Due to Selective Disruption of Choline Metabolism and Transport Systems in Cancer Cell Lines.
García-Molina P; Sola-Leyva A; Luque-Navarro PM; Laso A; Ríos-Marco P; Ríos A; Lanari D; Torretta A; Parisini E; López-Cara LC; Marco C; Carrasco-Jiménez MP
Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214160
[TBL] [Abstract][Full Text] [Related]
9. Gastrin-releasing peptide receptor-based targeting using bombesin analogues is superior to metabolism-based targeting using choline for in vivo imaging of human prostate cancer xenografts.
Schroeder RP; van Weerden WM; Krenning EP; Bangma CH; Berndsen S; Grievink-de Ligt CH; Groen HC; Reneman S; de Blois E; Breeman WA; de Jong M
Eur J Nucl Med Mol Imaging; 2011 Jul; 38(7):1257-66. PubMed ID: 21431398
[TBL] [Abstract][Full Text] [Related]
10. Activation of choline kinase drives aberrant choline metabolism in esophageal squamous cell carcinomas.
Ma W; Wang S; Zhang T; Zhang EY; Zhou L; Hu C; Yu JJ; Xu G
J Pharm Biomed Anal; 2018 Jun; 155():148-156. PubMed ID: 29631075
[TBL] [Abstract][Full Text] [Related]
11. The moonlighting function of glycolytic enzyme enolase-1 promotes choline phospholipid metabolism and tumor cell proliferation.
Ma Q; Jiang H; Ma L; Zhao G; Xu Q; Guo D; He N; Liu H; Meng Z; Liu J; Zhu L; Lin Q; Wu X; Li M; Luo S; Fang J; Lu Z
Proc Natl Acad Sci U S A; 2023 Apr; 120(15):e2209435120. PubMed ID: 37011206
[TBL] [Abstract][Full Text] [Related]
12. Choline metabolism in malignant transformation.
Glunde K; Bhujwalla ZM; Ronen SM
Nat Rev Cancer; 2011 Nov; 11(12):835-48. PubMed ID: 22089420
[TBL] [Abstract][Full Text] [Related]
13. Bench to Bedside Development of [
Challapalli A; Barwick TD; Dubash SR; Inglese M; Grech-Sollars M; Kozlowski K; Tam H; Patel NH; Winkler M; Flohr P; Saleem A; Bahl A; Falconer A; De Bono JS; Aboagye EO; Mangar S
Molecules; 2023 Dec; 28(24):. PubMed ID: 38138508
[TBL] [Abstract][Full Text] [Related]
14. MYC is a positive regulator of choline metabolism and impedes mitophagy-dependent necroptosis in diffuse large B-cell lymphoma.
Xiong J; Wang L; Fei XC; Jiang XF; Zheng Z; Zhao Y; Wang CF; Li B; Chen SJ; Janin A; Gale RP; Zhao WL
Blood Cancer J; 2017 Jul; 7(7):e0. PubMed ID: 28686226
[TBL] [Abstract][Full Text] [Related]
15. Targeting choline phospholipid metabolism: GDPD5 and GDPD6 silencing decrease breast cancer cell proliferation, migration, and invasion.
Cao MD; Cheng M; Rizwan A; Jiang L; Krishnamachary B; Bhujwalla ZM; Bathen TF; Glunde K
NMR Biomed; 2016 Aug; 29(8):1098-107. PubMed ID: 27356959
[TBL] [Abstract][Full Text] [Related]
16. Choline kinase inhibition in rheumatoid arthritis.
Guma M; Sanchez-Lopez E; Lodi A; Garcia-Carbonell R; Tiziani S; Karin M; Lacal JC; Firestein GS
Ann Rheum Dis; 2015 Jul; 74(7):1399-407. PubMed ID: 25274633
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of choline kinase renders a highly selective cytotoxic effect in tumour cells through a mitochondrial independent mechanism.
Rodríguez-González A; Ramírez de Molina A; Bañez-Coronel M; Megias D; Lacal JC
Int J Oncol; 2005 Apr; 26(4):999-1008. PubMed ID: 15753995
[TBL] [Abstract][Full Text] [Related]
18. Tumour volume delineation in prostate cancer assessed by [11C]choline PET/CT: validation with surgical specimens.
Bundschuh RA; Wendl CM; Weirich G; Eiber M; Souvatzoglou M; Treiber U; Kübler H; Maurer T; Gschwend JE; Geinitz H; Grosu AL; Ziegler SI; Krause BJ
Eur J Nucl Med Mol Imaging; 2013 Jun; 40(6):824-31. PubMed ID: 23389430
[TBL] [Abstract][Full Text] [Related]
19. Dysregulated choline metabolism in T-cell lymphoma: role of choline kinase-α and therapeutic targeting.
Xiong J; Bian J; Wang L; Zhou JY; Wang Y; Zhao Y; Wu LL; Hu JJ; Li B; Chen SJ; Yan C; Zhao WL
Blood Cancer J; 2015 Mar; 5(3):287. PubMed ID: 25768400
[TBL] [Abstract][Full Text] [Related]
20. Choline metabolism and its implications in cancer.
Yao N; Li W; Xu G; Duan N; Yu G; Qu J
Front Oncol; 2023; 13():1234887. PubMed ID: 38023163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
